The UK government has launched a £150 million ($185 million) procurement drive for artificial intelligence solutions that can ...

2025 is going to be a year of great change. At a macro level, political and geopolitical shifts around the world will reshape ...

The INTERCEPT study is being funded to the tune of €38 million (nearly $40 million) over the next five years and is described ...

The mental health clinical trials market is expected to double to $4.27 billion in 2028, up from $2.15 billion in 2018, and ...

A collaboration between data scientists, clinical researchers, and community opticians in the UK is hoping to develop an ...

Trump has so far not targeted any of Biden's signature healthcare policies, including Medicare drug pricing negotiation ...

The accelerating sales growth of Johnson & Johnson's Spravato could go up yet another gear after the FDA approved a third ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

One reason is the fact that much research related to ovarian cancer has focused on strategies combining chemotherapy with ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

Datapharm operates the electronic medicines compendium (emc), a trusted online resource for HCPs and patients, which attracts ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, ...